TXNIP potentiates Redd1-induced mTOR suppression through stabilization of Redd1

Area of Science:

• Molecular Biology
• Cellular Signaling
• Cancer Research

Background:

• The mammalian target of rapamycin (mTOR) pathway is crucial for cell growth and frequently dysregulated in cancer, making it a therapeutic target.
• Redd1 negatively regulates mTOR by facilitating the formation of the TSC-TSC2 complex.
• Understanding upstream regulators of mTOR is vital for developing targeted cancer therapies.

Purpose of the Study:

• To identify novel regulators of mTOR signaling.
• To investigate the role of TXNIP in the regulation of mTOR activity.
• To elucidate the mechanism by which TXNIP affects mTOR signaling, particularly in response to stress.

Main Methods:

• Investigated the interaction between TXNIP and Redd1.
• Utilized 2-deoxyglucose (2-DG) to induce stress and observed changes in Redd1 and TXNIP expression.
• Employed small interfering RNA (siRNA) to knockdown TXNIP and assess its effect on mTOR activity and Redd1 levels.

Main Results:

• TXNIP inhibits mTOR activity by binding to and stabilizing Redd1 protein.
• Expression of both Redd1 and TXNIP is induced by 2-DG, with Redd1 regulation dependent on ATF4.
• TXNIP overexpression reduces mTOR activity by increasing Redd1 levels; TXNIP knockdown restores mTOR activity by downregulating Redd1 during 2-DG treatment.

Conclusions:

• TXNIP acts as a novel negative regulator of mTOR signaling by stabilizing ATF4-induced Redd1 in response to 2-DG.
• This study identifies TXNIP as a key upstream component of the mTOR pathway, potentiating mTOR suppression under stress conditions.
• The findings highlight a new mechanism for controlling mTOR activity with potential implications for cancer therapy.